Scientists discover "electric spiking" communication in previously thought to be mute cells, paving the way for bioelectric ...
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369] Draft guidance Technology appraisal guidance 2 April ...